• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Colfax Corporation (Amendment)

    1/26/22 4:31:10 PM ET
    $CFX
    Fluid Controls
    Capital Goods
    Get the next $CFX alert in real time by email
    SC 13G/A 1 wf_colfaxcorp-194014205x.htm







    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934
    (Amendment No. 1)

    COLFAX CORP

    (Name of Issuer)

    UNIT 01/15/2022T

    (Title of Class of Securities)

    194014205

    (CUSIP Number)

    December 31, 2021

    (Date of Event Which Requires Filing of this Statement)
     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [X]Rule 13d-1(b)
    []Rule 13d-1(c)
    []Rule 13d-1(d)

    The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be 'filed' for the purpose of Section 18 of the Securities Exchange Act of 1934 ('Act') or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     
    CUSIP No. 194014205

    Person 1
     1.(a) Names of Reporting Persons.
    Wells Fargo & Company
     (b) Tax ID
    41-0449260

     2.Check the Appropriate Box if a Member of a Group (See Instructions)
      (a)  []
      (b)  []

     3.SEC Use Only . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

     4.Citizenship or Place of Organization   Delaware

    Number of
    Shares
    Beneficially
    Owned by
    Each Reporting
    Person With
    5. Sole Voting Power 3,000

    6.  Shared Voting Power 0

    7. Sole Dispositive Power 3,000

    8. Shared Dispositive Power 0


    9.Aggregate Amount Beneficially Owned by Each Reporting Person 3,000


    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)


    11. Percent of Class Represented by Amount in Row (9)  0.24 %


    12. Type of Reporting Person (See Instructions)

    HC

    Item 1.
     (a)Name of Issuer
    COLFAX CORP
     (b)Address of Issuer's Principal Executive Offices
      2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON, DE 19808
    Item 2.
     (a)Name of Person Filing
    Wells Fargo & Company
     (b)Address of Principal Business Office or, if none, Residence
    420 Montgomery Street, San Francisco, CA 94163
     (c)Citizenship
    Delaware
     (d)Title of Class of Securities
    UNIT 01/15/2022T
     (e)CUSIP Number
    194014205
     
    Item 3.If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c)
    (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
    (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
    (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940
    (15 U.S.C 80a-8).
    (e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
    (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
    (g) [X ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
    (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act
    (12 U.S.C. 1813);
    (i) [ ] A church plan that is excluded from the definition of an investment company under section
    3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j) [ ] A non-U.S.institution in accordance with 240.13d-1(b)(1)(ii)(J);
    (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K).
    If filing as a non-U.S.institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ______________
     
    Item 4.Ownership.
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
      (a) Amount beneficially owned:  3,000
     (b) Percent of class:  0.24%
     (c)Number of shares as to which the person has:
      (i) Sole power to vote or to direct the vote 3,000
      (ii) Shared power to vote or to direct the vote  0
       (iii) Sole power to dispose or to direct the disposition of 3,000
       (iv) Shared power to dispose or to direct the disposition of 0
     
     
    Item 5.Ownership of Five Percent or Less of a Class
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.[X ].
     
    Item 6.Ownership of More than Five Percent on Behalf of Another Person.
    Not applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
    See Exhibit B
    Item 8. Identification and Classification of Members of the Group
    Not applicable.
    Item 9.Notice of Dissolution of Group
    Not applicable.
    Item 10.Certification
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    January 20, 2022
    Date
    /s/ Patricia Arce
    Signature
    Patricia Arce, Designated Signer
    Name/Title
    Exhibit A
    EXPLANATORY NOTE

    This Schedule 13G is filed by Wells Fargo & Company on its own behalf and on behalf of any subsidiaries listed in Exhibit B. Aggregate beneficial ownership reported by Wells Fargo & Company under Item 9 on page 2 is on a consolidated basis and includes any beneficial ownership separately reported herein by a subsidiary.
    Exhibit B
    The Schedule 13G to which this attachment is appended is filed by Wells Fargo & Company on behalf of the following subsidiaries:

    Wells Fargo Securities, LLC (1)

    (1) Classified as a broker dealer in accordance with Regulation 13d-1(b)(1)(ii)(A).

     

     

    Attention:Intentional misstatements or omissions of fact constitute Federal criminal violations
    (See 18 U.S.C. 1001)
    Get the next $CFX alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CFX

    DatePrice TargetRatingAnalyst
    3/2/2022$8.00 → $7.00Sector Perform
    RBC Capital
    2/23/2022$58.00 → $52.00Buy
    Stifel
    2/8/2022Buy → Neutral
    Seaport Global
    1/28/2022$51.00 → $45.00Equal-Weight
    Morgan Stanley
    1/14/2022$56.00 → $51.00Equal-Weight
    Morgan Stanley
    1/6/2022$45.00Hold
    Loop Capital
    11/5/2021$57.00 → $60.00Overweight
    Keybanc
    10/20/2021$12.00 → $9.00Outperform → Sector Perform
    RBC Capital
    More analyst ratings

    $CFX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Kleckner John sold $2,496 worth of shares (44 units at $56.73), decreasing direct ownership by 3% to 1,661 units (for tax liability)

      4 - Enovis CORP (0001420800) (Issuer)

      7/21/22 8:00:15 PM ET
      $CFX
      Fluid Controls
      Capital Goods
    • SEC Form 4: Perfall A Clayton was granted 432 shares, increasing direct ownership by 1% to 31,073 units

      4 - Enovis CORP (0001420800) (Issuer)

      7/1/22 7:00:22 PM ET
      $CFX
      Fluid Controls
      Capital Goods
    • SEC Form 4: Lalor Angela S was granted 319 shares, increasing direct ownership by 16% to 2,363 units

      4 - Enovis CORP (0001420800) (Issuer)

      7/1/22 7:00:17 PM ET
      $CFX
      Fluid Controls
      Capital Goods

    $CFX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Enovis (formerly Colfax) Completes Spin-off of ESAB Corporation

      Wilmington, DE, April 05, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation ("Enovis" or the "Company") (NYSE:ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, announced today the completion of its previously announced separation (the "Separation") of its fabrication technology business into an independent, publicly traded company, ESAB Corporation ("ESAB") (NYSE:ESAB). Immediately following the Separation, Enovis effected its previously announced reverse stock split of all issued and outstanding shares of Enovis common stock at a one-for-three ratio. Enovis and ESAB common stock will each begin regular-way trading today, April 5, 2022, on t

      4/5/22 6:00:00 AM ET
      $CFX
      Fluid Controls
      Capital Goods
    • ESAB Set to Join S&P MidCap 400; PROG Holdings to Join S&P SmallCap 600

      NEW YORK, March 30, 2022 /PRNewswire/ -- ESAB Corp. (NYSE:ESAB) will be added to the S&P MidCap 400 effective prior to the opening of trading on Tuesday, April 5. Effective prior to the opening of trading on Wednesday, April 6, S&P MidCap 400 constituent PROG Holdings Inc. (NYSE:PRG) will replace Fiesta Restaurant Group Inc. (NASD: FRGI) in the S&P SmallCap 600. S&P MidCap 400 constituent Colfax Corp. (NYSE:CFX) is spinning off ESAB in a transaction expected to be completed on April 5. Post spin-off, Colfax will be renamed Enovis Corp. (NYSE:ENOV) and will remain in the S&P MidCap 400. PROG Holdings is more representative of the small-cap market space and Fiesta Restaurant Group is no longer

      3/30/22 8:21:00 PM ET
      $CFX
      $FRGI
      $PRG
      $SPGI
      Fluid Controls
      Capital Goods
      Restaurants
      Consumer Discretionary
    • Colfax Announces Board of Directors for Post-Spinoff ESAB

      Wilmington, DE, March 28, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE:CFX), a leading diversified technology company which will renamed Enovis Corporation ("Enovis") following the expected April 4, 2022 consummation of the Company's previously announced spin-off of its fabrication technology business (the "Separation"), which will operate as ESAB Corporation ("ESAB") after the Separation, today announced the future composition of the full ESAB Board of Directors (the "Board"). Following the Separation, Mitchell P. Rales will serve as chairman of the Board, and current Colfax directors Patrick W. Allender, Rhonda L. Jordan, Didier Teirlinck and Rajiv Vinnakota will serve as directo

      3/28/22 6:30:00 AM ET
      $CFX
      Fluid Controls
      Capital Goods

    $CFX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • RBC Capital reiterated coverage on Canfor Pulp Products with a new price target

      RBC Capital reiterated coverage of Canfor Pulp Products with a rating of Sector Perform and set a new price target of $7.00 from $8.00 previously

      3/2/22 7:16:55 AM ET
      $CFX
      Fluid Controls
      Capital Goods
    • Stifel reiterated coverage on Colfax with a new price target

      Stifel reiterated coverage of Colfax with a rating of Buy and set a new price target of $52.00 from $58.00 previously

      2/23/22 8:55:36 AM ET
      $CFX
      Fluid Controls
      Capital Goods
    • Colfax downgraded by Seaport Global

      Seaport Global downgraded Colfax from Buy to Neutral

      2/8/22 6:36:17 AM ET
      $CFX
      Fluid Controls
      Capital Goods

    $CFX
    SEC Filings

    See more
    • Colfax Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - Enovis CORP (0001420800) (Filer)

      6/30/22 8:23:02 AM ET
      $CFX
      Fluid Controls
      Capital Goods
    • SEC Form 11-K filed by Colfax Corporation

      11-K - Enovis CORP (0001420800) (Filer)

      6/29/22 3:02:16 PM ET
      $CFX
      Fluid Controls
      Capital Goods
    • Colfax Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Enovis CORP (0001420800) (Filer)

      6/13/22 4:14:55 PM ET
      $CFX
      Fluid Controls
      Capital Goods

    $CFX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Colfax Corporation

      SC 13G - Enovis CORP (0001420800) (Subject)

      4/21/22 3:32:21 PM ET
      $CFX
      Fluid Controls
      Capital Goods
    • SEC Form SC 13G/A filed by Colfax Corporation (Amendment)

      SC 13G/A - Colfax CORP (0001420800) (Subject)

      3/11/22 2:13:51 PM ET
      $CFX
      Fluid Controls
      Capital Goods
    • SEC Form SC 13G/A filed by Colfax Corporation (Amendment)

      SC 13G/A - Colfax CORP (0001420800) (Subject)

      2/9/22 3:43:31 PM ET
      $CFX
      Fluid Controls
      Capital Goods

    $CFX
    Financials

    Live finance-specific insights

    See more
    • Colfax Corporation Announces Fourth Quarter and Full Year 2021 Results

      Strong operating performance supported $0.06 EPS from continuing operations and $0.59 of adjusted EPSAchieved a strong quarter of cash flow, contributing to full year operating cash flow of $356 million and free cash flow of $277 millionPositioned for separation into two independent public companies near the end of the first quarter 2022 with strong growth outlooks for both businesses Wilmington, DE, Feb. 22, 2022 (GLOBE NEWSWIRE) --  Colfax Corporation (NYSE:CFX), a leading diversified technology company, today announced its financial results for the fourth quarter and fiscal year 2021 and provided additional updates. The Company reported fourth quarter net income from c

      2/22/22 6:00:00 AM ET
      $CFX
      Fluid Controls
      Capital Goods
    • Colfax Schedules Fourth Quarter and Fiscal Year 2021 Earnings Release and Conference Call

            Wilmington DE, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE:CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the fourth quarter and fiscal year 2021 on the morning of Tuesday, February 22, 2022. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-877-303-7908 (U.S. callers) and +1-678-373-0875 (International callers) and referencing the conference ID number 7466839 and through webcast via Colfax's website www.colfaxcorp.com under the "Investors" section. Colfax's financial results

      1/20/22 5:00:23 PM ET
      $CFX
      Fluid Controls
      Capital Goods
    • Colfax Corporation Announces Third Quarter 2021 Results

                                                     Posted $0.17 EPS from continuing operations and $0.54 of adjusted EPSIncreased sales 20% to $966 million including a 15% organic sales-per-day improvementReported strong progress on integration of acquisitionsAnnounced continued progress to Q1 2022 separation including new post-separation name for MedTech growth company WILMINGTON, DE, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE:CFX), a leading diversified technology company, today announced its financial results for the third quarter of 2021 and provided other updates. The Company reported third quarter net income from continuing operations of $27 million, or $0

      11/4/21 6:00:00 AM ET
      $CFX
      Fluid Controls
      Capital Goods